about
The clinical toxicology of metamfetamineCustomizing monoclonal antibodies for the treatment of methamphetamine abuse: current and future applicationsFenethylline (Captagon) Abuse - Local Problems from an Old Drug Become Universal.MDMA and methamphetamine: some paradoxical negative and positive mood changes in an acute dose laboratory study.Psychomotor effect differences between l-methamphetamine and d-methamphetamine are independent of murine plasma and brain pharmacokinetics profilesMethamphetamine causes sustained depression in cerebral blood flowRapid quantitative chiral amphetamines liquid chromatography-tandem mass spectrometry: method in plasma and oral fluid with a cost-effective chiral derivatizing reagentA randomized, placebo-controlled trial of sustained-release dextroamphetamine for treatment of methamphetamine addiction.Estimating the intake of abused methamphetamines using experimenter-administered deuterium labeled R-methamphetamine: selection of the R-methamphetamine dose.Impact of distinct chemical structures for the development of a methamphetamine vaccineChiral toxicology: it's the same thing...only different.Developing biomarkers for methamphetamine addiction.Methamphetamine: here we go again?Selegiline transdermal system (STS) as an aid for smoking cessation.Oral fluid with three modes of collection and plasma methamphetamine and amphetamine enantiomer concentrations after controlled intranasal l-methamphetamine administration.Effects of L-methamphetamine treatment on cocaine- and food-maintained behavior in rhesus monkeys.The clinical pharmacology of intranasal l-methamphetamineAcute myocardial infarction in young adults who abuse amphetamines.Effect of +-methamphetamine on path integration learning, novel object recognition, and neurotoxicity in ratsMethamphetamine compromises gap junctional communication in astrocytes and neurons.PET studies of d-methamphetamine pharmacokinetics in primates: comparison with l-methamphetamine and ( --)-cocaine.Essential/precursor chemicals and drug consumption: impacts of US sodium permanganate and Mexico pseudoephedrine controls on the numbers of US cocaine and methamphetamine users.Comparison of some behavioral effects of d- and l-methamphetamine in adult male rats.Electrophysiological Actions of Synthetic Cathinones on Monoamine Transporters.Effects of acute and chronic systemic methamphetamine on respiratory, cardiovascular and metabolic function, and cardiorespiratory reflexes.Stereoselectivity in the human metabolism of methamphetamine.The neurobiological mechanisms of physical exercise in methamphetamine addiction.Cocaine-like discriminative stimulus effects of "norepinephrine-preferring" monoamine releasers: time course and interaction studies in rhesus monkeys.Immunoassay cross-reactivity of phenylephrine and methamphetamine.A new survey of methamphetamine users in treatment: who they are, why they like "meth," and why they need additional services.
P2860
Q22305685-8BD0DC96-F66C-4BCA-A3D5-4EC82EBA47B3Q26864041-DDBB75CB-B90A-48FA-824B-FFD57DD48985Q30251734-34EE7691-447C-4370-9807-8AF503982D16Q33390410-66534077-85DE-4710-9B05-1B0684155DC6Q33586226-1675938E-A8E0-4BFF-ADE0-43DF7262CC7FQ33771269-C46EFF86-67D9-4DE3-AF78-E5875C485572Q34115227-E1B1A0BD-19E3-467C-BC54-BABEBBB7880FQ34156209-D6223526-0103-4A93-A587-2EFE11CEF1E9Q34580744-9BD2BB67-F652-4B63-AA5D-363FF0D6609AQ34956542-650F047D-AC64-4ACD-8D13-C50307CBA38DQ34979115-E027A509-7A1C-4307-9CAD-A4F8A4ED3653Q35107735-A5437385-A4A0-4E6B-A37E-E1D251041124Q35627321-BC4046B9-8E7F-46E0-B80F-985D97BB4B48Q35761733-8DA4B7A9-BBD9-474B-8DF9-444BE5AF520AQ36073197-B21A6964-874C-46DD-8AE2-32B51CC30DD3Q36600161-D860FFE7-E47F-4126-932A-E13E0EAE629FQ36812582-99513934-F084-461D-BB92-1A54CB67581EQ36869525-B72D032D-4BDE-4E98-A043-630A70DFFDB5Q36924648-625B746F-BD9C-4632-ADD8-83AF653FDA5DQ37311336-97D23D06-463C-4888-8225-481EFBB02447Q37319768-5415871A-DD63-445E-A22E-040C86582A92Q38406104-4C9E5F57-33B5-4603-BABB-AAD3E7586F14Q38733781-EEA4228B-14A6-4925-9625-224959D2093DQ38966221-A1A772AB-FB0B-41EA-94C3-9EDC6BACCB4DQ40301697-47CC8F65-16E3-4C25-970C-149F96BECD50Q41825370-DE52136C-6F7F-4D01-9B93-8233C368A28EQ47268750-13552D0C-91A7-4FD5-BC2E-AD55DC62CF67Q48007597-7E049BC0-03E1-46B1-AEE3-9828605FF9E5Q48570163-371E65A0-31B2-4AAE-84A2-8BD8FD5EB6E7Q50687688-2065A0F1-CC33-41AD-A513-604EC624C5A5
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Human pharmacology of the methamphetamine stereoisomers
@ast
Human pharmacology of the methamphetamine stereoisomers
@en
Human pharmacology of the methamphetamine stereoisomers
@nl
type
label
Human pharmacology of the methamphetamine stereoisomers
@ast
Human pharmacology of the methamphetamine stereoisomers
@en
Human pharmacology of the methamphetamine stereoisomers
@nl
prefLabel
Human pharmacology of the methamphetamine stereoisomers
@ast
Human pharmacology of the methamphetamine stereoisomers
@en
Human pharmacology of the methamphetamine stereoisomers
@nl
P2093
P1476
Human pharmacology of the methamphetamine stereoisomers
@en
P2093
Debra Harris
E Thomas Everhart
Emilio Fernandez
John Mendelson
Naoto Uemura
Peyton Jacob
Rajneesh P Nath
Reese T Jones
P304
P356
10.1016/J.CLPT.2006.06.013
P407
P577
2006-10-01T00:00:00Z